Caribou Biosciences (CRBU) Change in Cash (2020 - 2025)
Caribou Biosciences has reported Change in Cash over the past 6 years, most recently at $1.2 million for Q4 2025.
- Quarterly Change in Cash rose 107.76% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.9 million through Dec 2025, up 88.72% year-over-year, with the annual reading at -$3.9 million for FY2025, 88.72% up from the prior year.
- Change in Cash was $1.2 million for Q4 2025 at Caribou Biosciences, up from -$14.1 million in the prior quarter.
- Over five years, Change in Cash peaked at $305.8 million in Q3 2021 and troughed at -$194.9 million in Q4 2021.
- The 5-year median for Change in Cash is -$8.7 million (2024), against an average of -$177350.0.
- The largest YoY upside for Change in Cash was 3662.69% in 2021 against a maximum downside of 2167.74% in 2021.
- A 5-year view of Change in Cash shows it stood at -$194.9 million in 2021, then soared by 87.82% to -$23.7 million in 2022, then crashed by 122.75% to -$52.9 million in 2023, then skyrocketed by 70.36% to -$15.7 million in 2024, then soared by 107.76% to $1.2 million in 2025.
- Per Business Quant, the three most recent readings for CRBU's Change in Cash are $1.2 million (Q4 2025), -$14.1 million (Q3 2025), and -$4.2 million (Q2 2025).